See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus
Method of treatment using Lactobacillus fermentum ME-3
Patentne leiutis: Method of treatment using Lactobacillus fermentum ME-3; Omanikud: Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut; Autorid: Tiiu Kullisaar, Mihkel Zilmer, Imbi Smidt, Kersti Zilmer, Marika Mikelsaar, Pirje Hütt; Prioriteedi number: WO2013IB61216 20131220; GB20120023370 20121224; Prioriteedi kuupäev: 14.09.2015.
Patentne leiutis
Method of treatment using Lactobacillus fermentum ME-3
The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component,a metabolic syndrome related disorder selected from prediabetes, type 2 diabetes and cardiovascular disease. The effect may be achieved by simultaneously:decreasing the level of glycated haemoglobin HbA1c, decreasing or preventing low-grade inflammation on a cellular level and increasing the level of adiponectin.
Prioriteeditaotlus
14.09.2015
WO2013IB61216 20131220; GB20120023370 20121224
Rahvusvaheline (IPC)
United States Patent US9974817 B2 date of patent May 22, 2018 European Patent EP2943210 B1
A61K35/74; A61P3/10; A61P39/06; A61P9/10
European Patent Office
Muu...
Kaitstud